1. Home
  2. NURO vs BREA Comparison

NURO vs BREA Comparison

Compare NURO & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • BREA
  • Stock Information
  • Founded
  • NURO 1996
  • BREA 2022
  • Country
  • NURO United States
  • BREA Ireland
  • Employees
  • NURO N/A
  • BREA N/A
  • Industry
  • NURO Medical/Dental Instruments
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • NURO Health Care
  • BREA Consumer Discretionary
  • Exchange
  • NURO Nasdaq
  • BREA Nasdaq
  • Market Cap
  • NURO 8.2M
  • BREA 8.7M
  • IPO Year
  • NURO N/A
  • BREA 2023
  • Fundamental
  • Price
  • NURO $4.38
  • BREA $0.64
  • Analyst Decision
  • NURO
  • BREA
  • Analyst Count
  • NURO 0
  • BREA 0
  • Target Price
  • NURO N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • NURO 21.7K
  • BREA 61.7K
  • Earning Date
  • NURO 02-20-2025
  • BREA 01-03-2025
  • Dividend Yield
  • NURO N/A
  • BREA N/A
  • EPS Growth
  • NURO N/A
  • BREA N/A
  • EPS
  • NURO N/A
  • BREA N/A
  • Revenue
  • NURO $3,767,764.00
  • BREA $2,872,101.00
  • Revenue This Year
  • NURO N/A
  • BREA N/A
  • Revenue Next Year
  • NURO N/A
  • BREA N/A
  • P/E Ratio
  • NURO N/A
  • BREA N/A
  • Revenue Growth
  • NURO N/A
  • BREA 2338.69
  • 52 Week Low
  • NURO $2.66
  • BREA $0.50
  • 52 Week High
  • NURO $4.73
  • BREA $3.00
  • Technical
  • Relative Strength Index (RSI)
  • NURO 67.97
  • BREA 40.04
  • Support Level
  • NURO $4.16
  • BREA $0.62
  • Resistance Level
  • NURO $4.40
  • BREA $0.69
  • Average True Range (ATR)
  • NURO 0.09
  • BREA 0.05
  • MACD
  • NURO 0.03
  • BREA -0.01
  • Stochastic Oscillator
  • NURO 95.24
  • BREA 15.31

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: